Biotherapy for xenografted human central nervous system leukemia in mice with severe combined immunodeficiency using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin. [electronic resource]
Producer: 19950531Description: 2537-45 p. digitalISSN:- 0006-4971
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antigens, CD -- immunology
- Antigens, CD19
- Antigens, Differentiation, B-Lymphocyte -- immunology
- Blood-Brain Barrier
- Bone Marrow -- pathology
- Cell Movement
- Central Nervous System -- pathology
- DNA, Neoplasm -- analysis
- Drug Evaluation, Preclinical
- Immunotoxins -- administration & dosage
- Injections, Intraperitoneal
- Injections, Intravenous
- Injections, Spinal
- Leukemic Infiltration -- drug therapy
- Meninges -- pathology
- Methotrexate -- therapeutic use
- Mice
- Mice, SCID
- N-Glycosyl Hydrolases
- Neoplasm Transplantation
- Neoplastic Cells, Circulating
- Plant Proteins -- administration & dosage
- Polymerase Chain Reaction
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Ribosome Inactivating Proteins, Type 1
- Specific Pathogen-Free Organisms
- Transplantation, Heterologous
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.